Workflow
Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries
Globenewswire· 2025-06-04 12:00
Medicinal leeches are increasingly used in the GCC to treat diverse medical conditions including venous congestion, which is a buildup of blood in the veins, and to aid in tissue healing and circulation following reconstructive and microsurgery procedures. The leeches are also used to relieve symptoms of osteoarthritis as well as in veterinary surgery, especially to help treat polycythaemia vera, a chronic blood cancer. "We are excited to complete both of these milestones," said Cuprina chief executive Davi ...
Repeat: Rocket Doctor, a Treatment.com AI company, Joins Larta Institute’s 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care
Globenewswire· 2025-06-04 12:00
Selection aims to accelerate Rocket Doctor's mission to deliver accessible, tech-enabled care to underserved communities. Visit www.rocketdoctor.io or contact media@rocketdoctor.io. About the Larta Institute Larta Institute is a Los Angeles-based 501(c)(3) nonprofit that accelerates innovation for impact. Since 1993, Larta has supported more than 4,300 startups through programs that connect science and technology TORONTO, ON, June 04, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Fr ...
Oman Telecommunication Company (Omantel) and GlobalTech Corporation Enter Into Non-Binding Memorandum of Understanding Relating to Potential Revenue Share Arrangement on AI & Big Data Services
Globenewswire· 2025-06-04 12:00
RENO, Nev., June 04, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (GTC, OTC:GTLK) ("GlobalTech"), a technology holding company specializing in artificial intelligence (AI) and big data products and Omantel (www.omantel.om), Oman's leading telecommunications provider, announced that they have signed a Memorandum of Understanding (MoU) to explore a collaboration on AI & Big Data services. The non-binding MoU establishes the parties' mutual interest in exploring and advancing technological innovations, spec ...
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Globenewswire· 2025-06-04 12:00
Phase 1 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors Previous clinical proof-of concept data for targeting HER-2 demonstrated the safety and biodistribution of 99mTc-RAD202 in humans SYDNEY, June 04, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncol ...
Marimaca Copper Announces Proposed US$17.7 Million Non-Brokered Private Placement
Globenewswire· 2025-06-04 12:00
Not for distribution to U.S. newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities law. VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. ("Marimaca" or the "Company") (TSX: MARI) (ASX: MC2) is pleased to announce a proposed non- brokered private placement (the "Private Placement") of an aggregate of 5,311,416 common shares of the Company (the "Shares") at a price of C$4.60 per ...
Fusion Fuel Green PLC Announces Forthcoming Annual General Meeting
Globenewswire· 2025-06-04 12:00
DUBLIN, June 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (Nasdaq: HTOO) ("Fusion Fuel" or the "Company") today announced that it will hold its Annual General Meeting ("AGM") on June 25, 2025, at 2:00 PM (Dublin time) at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland. Shareholders are encouraged to review the Notice of AGM, which has been furnished to the U.S. Securities and Exchange Commission ("SEC") with a Report on Form 6-K and mailed to all shareholder ...
Premier Air Charter Holdings Inc. Announces Ticker Symbol Change
Globenewswire· 2025-06-04 12:00
About Premier Air Charter, Inc. Premier Air Charter's dedication to excellence extends beyond its aircraft, encompassing personalized service, attention to detail, and uncompromising safety standards. Premier Air Charter is leading the way in luxury aviation. Our vast fleet of aircraft includes everything from light jets and turbojets to mid-large Jets. Drawing on decades of experience, our aviation experts oversee every aspect of the jet charter business, including private charters, aircraft management and ...
reAlpha Appoints Mike Logozzo as CEO to Accelerate Growth
Globenewswire· 2025-06-04 12:00
Founder Giri Devanur Transitions to Executive Chairman About reAlpha Tech Corp. DUBLIN, Ohio, June 04, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) ("reAlpha" or the "Company"), an AI-powered real estate technology company, today announced a strategic leadership transition to support its next phase of growth. Effective June 3, 2025, Mike Logozzo, President and Chief Operating Officer, has been appointed Chief Executive Officer, and Giri Devanur, reAlpha's founder, Chairman of the Board and for ...
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
Globenewswire· 2025-06-04 12:00
Akebia continues to publish important, clinically relevant data to further physicians' understanding of Vafseo® (vadadustat) The vadadustat global phase 3 clinical trials were open-label, randomized, noninferiority trials that compared the safety and efficacy of vadadustat with darbepoetin alfa in adult patients with CKD-related anemia. Data from the pre-specified analyses for the U.S. patient subgroup demonstrate that among patients with DD-CKD, safety and efficacy of vadadustat and darbepoetin alfa in the ...
Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector
Globenewswire· 2025-06-04 12:00
Greensboro, NC, June 04, 2025 (GLOBE NEWSWIRE) -- Global Technologies, LTD (OTCPK: GTLL), a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership. Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL's sharpened ...